专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

US20200223793A1 ISOTOPE-ENRICHED 3-AMINO-1-PROPANESULFONIC ACID DERIVATIVES AND USES THEREOF 审中-公开
公开(公告)号：US20200223793A1
公开(公告)日：2020-07-16
申请号：US16655311
申请日：2019-10-17
申请人： RISEN (SUZHOU) PHARMA TECH CO., LTD.
发明人： Jiasheng LU , Jiamin GU , Xinyong LV , Guowei SONG , Dongdong WU , Daiqiang HU , Jun GU , Gang CHEN , Xiang JI , Xiuchun ZHANG , Jinchao AI , Xianqi KONG
IPC分类号： C07C309/14 , C07C309/15 , C07B59/00 , C07C309/59 , C07D233/61
摘要： There are provided isotope-enriched compounds of Formula (I) and pharmaceutically acceptable salts or esters thereof, as well as pharmaceutical compositions thereof and methods of use thereof for prevention and treatment of amyloid-β related diseases, such as Alzheimer's disease. R1R2X—CR2—CH2—CH2—SO3H (I)

2. 发明授权

US09169210B2 Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex 有权
公开(公告)号：US09169210B2
公开(公告)日：2015-10-27
申请号：US13603965
申请日：2012-09-05
申请人： Robert Eugene Hormann , David W. Potter , Orestes Chortyk , Colin M. Tice , Glenn Richard Carlson , Andrew Meyer , Thomas R. Opie
发明人： Robert Eugene Hormann , David W. Potter , Orestes Chortyk , Colin M. Tice , Glenn Richard Carlson , Andrew Meyer , Thomas R. Opie
IPC分类号： C07C243/38 , C07D213/63 , C07D213/87 , C07C243/24 , C07C251/08 , C07C251/38 , C07C255/66 , C07C281/10 , C07C309/59 , C07C317/44 , C07C317/46 , C07D209/42 , C07D213/81 , C07D213/82 , C07D231/14 , C07D231/56 , C07D235/06 , C07D237/24 , C07D239/52 , C07D241/24 , C07D271/12 , C07D317/68 , C07D319/18 , C07D405/12 , C07C243/18
CPC分类号： C07C241/04 , A61K31/166 , A61K31/222 , A61K31/357 , A61K31/404 , A61K31/415 , A61K31/4184 , A61K31/455 , A61K31/4965 , C07C243/18 , C07C243/24 , C07C243/38 , C07C251/08 , C07C251/38 , C07C255/66 , C07C281/10 , C07C309/59 , C07C315/02 , C07C317/44 , C07C317/46 , C07D209/42 , C07D213/81 , C07D213/82 , C07D213/86 , C07D213/87 , C07D231/14 , C07D231/56 , C07D235/06 , C07D235/24 , C07D237/24 , C07D239/52 , C07D241/24 , C07D271/12 , C07D317/68 , C07D319/08 , C07D319/18 , C07D319/20 , C07D405/12 , C12N9/0069 , C12N15/635 , C12P21/00 , Y02A50/471
摘要： The present invention relates to non-steroidal ligands for use in nuclear receptor-based inducible gene expression system, and a method to modulate exogenous gene expression in which an ecdysone receptor complex comprising: a DNA binding domain; a ligand binding domain; a transactivation domain; and a ligand is contacted with a DNA construct comprising: the exogenous gene and a response element; wherein the exogenous gene is under the control of the response element and binding of the DNA binding domain to the response element in the presence of the ligand results in activation or suppression of the gene.

3. 发明申请

US20100286149A1 NOVEL BENZAMIDE DERIVATIVES USEFUL AS POTASSIUM CHANNEL MODULATORS 审中-公开
标题翻译：新的苯甲酸衍生物作为钾通道调节剂有用
公开(公告)号：US20100286149A1
公开(公告)日：2010-11-11
申请号：US12744662
申请日：2008-11-25
申请人： Antonio Nardi , Jeppe Kejser Christensen
发明人： Antonio Nardi , Jeppe Kejser Christensen
IPC分类号： A61K31/5377 , C07D271/07 , A61K31/4245 , C07D257/04 , A61K31/41 , C07C309/59 , A61K31/185 , C07D413/12 , C07C233/80 , A61K31/167 , A61P25/28 , A61P25/00 , A61P25/16 , A61P29/00 , A61P25/18 , A61P9/12 , A61P13/00 , A61P9/10 , A61P3/10 , A61P15/00
CPC分类号： C07D257/04 , C07C259/18 , C07C309/51 , C07D261/12 , C07D413/10
摘要： This invention relates to novel benzamide derivatives that are found to be potent modulators of potassium channels and, as such, are valuable candidates for the treatment of diseases or disorders as diverse as those which are responsive to the modulation of potassium channels.
摘要翻译：本发明涉及被发现是钾通道的有效调节剂的新型苯甲酰胺衍生物，因此是治疗与钾通道调节有关的疾病或病症多种多样的有价值的候选物。

4. 发明授权

US6071510A Modified amino acids and compositions comprising the same for delivering active agents 失效
标题翻译：修饰的氨基酸和包含其的组合物用于递送活性剂
公开(公告)号：US6071510A
公开(公告)日：2000-06-06
申请号：US839094
申请日：1997-04-23
申请人： Andrea Leone-Bay , Koc-Kan Ho , Jeffery Bruce Press , Nai-Fang Wang
发明人： Andrea Leone-Bay , Koc-Kan Ho , Jeffery Bruce Press , Nai-Fang Wang
IPC分类号： A61K9/00 , A61K9/16 , A61K38/21 , A61K38/23 , A61K38/27 , A61K38/29 , A61K47/18 , A61K47/20 , A61K47/22 , C07C233/34 , C07C233/47 , C07C233/48 , C07C233/51 , C07C233/52 , C07C233/54 , C07C233/55 , C07C233/63 , C07C233/81 , C07C233/83 , C07C233/84 , C07C233/87 , C07C235/24 , C07C235/34 , C07C235/38 , C07C235/40 , C07C235/60 , C07C235/64 , C07C235/82 , C07C237/22 , C07C237/40 , C07C237/42 , C07C259/06 , C07C271/22 , C07C309/59 , C07C311/19 , C07D207/34 , C07D213/81 , C07D295/215 , C07D317/68 , C07D333/38 , A61K31/70 , A61K38/17 , A61K47/12 , C07C229/06
CPC分类号： C07D213/81 , A61K38/212 , A61K38/23 , A61K38/27 , A61K38/29 , A61K47/18 , A61K47/183 , A61K47/20 , A61K47/22 , A61K47/4803 , A61K9/1617 , C07C233/34 , C07C233/47 , C07C233/48 , C07C233/51 , C07C233/52 , C07C233/54 , C07C233/55 , C07C233/63 , C07C233/81 , C07C233/83 , C07C233/84 , C07C233/87 , C07C235/24 , C07C235/34 , C07C235/38 , C07C235/40 , C07C235/60 , C07C235/64 , C07C235/82 , C07C237/22 , C07C237/40 , C07C237/42 , C07C259/06 , C07C271/22 , C07C309/59 , C07C311/19 , C07D207/34 , C07D295/215 , C07D317/68 , C07D333/38 , A61K9/0043 , A61K9/0056 , C07C2101/14 , C07C2101/18 , C07C2103/74
摘要： The present invention provides modified amino acids for delivering active agents, and particularly biologically or chemically active agents. The preferred modified amino acids of the present invention include N-acylated or sulfonated amino acids. These modified amino acids are used as carriers to facilitate the delivery of a cargo to a target. Such modified amino acids are well suited to form non-covalent mixtures with biologically-active agents for oral administration to animals. Methods for the preparation and administration of the modified amino acids and compositions including the same are also provided.
摘要翻译：本发明提供用于递送活性剂，特别是生物或化学活性剂的改性氨基酸。本发明优选的修饰氨基酸包括N-酰化或磺化的氨基酸。这些修饰的氨基酸用作载体以便于将货物运送到目标物。这种修饰的氨基酸非常适合于与动物口服给药的生物活性剂形成非共价混合物。还提供了修饰氨基酸的制备和给药方法及其组合物。

5. 发明授权

US5866536A Compounds and compositions for delivering active agents 失效
标题翻译：用于递送活性剂的化合物和组合物
公开(公告)号：US5866536A
公开(公告)日：1999-02-02
申请号：US798033
申请日：1997-02-06
申请人： Andrea Leone-Bay , Koc-Kan Ho , Donald J. Sarubbi , Sam J. Milstein
发明人： Andrea Leone-Bay , Koc-Kan Ho , Donald J. Sarubbi , Sam J. Milstein
IPC分类号： C07D295/20 , A61K9/00 , A61K9/08 , A61K9/16 , A61K9/20 , A61K9/48 , A61K31/197 , A61K31/198 , A61K31/40 , A61K31/44 , A61K38/00 , A61K38/04 , A61K38/11 , A61K38/21 , A61K38/22 , A61K38/23 , A61K38/27 , A61K38/28 , A61K38/29 , A61K39/00 , A61K39/395 , A61K45/00 , A61K47/12 , A61K47/16 , A61K47/18 , A61K47/20 , A61K47/22 , A61K47/48 , C07C53/126 , C07C53/134 , C07C229/08 , C07C229/10 , C07C229/42 , C07C231/12 , C07C233/34 , C07C233/47 , C07C233/48 , C07C233/51 , C07C233/52 , C07C233/54 , C07C233/55 , C07C233/63 , C07C233/81 , C07C233/83 , C07C233/84 , C07C233/87 , C07C235/24 , C07C235/34 , C07C235/38 , C07C235/40 , C07C235/52 , C07C235/56 , C07C235/60 , C07C235/62 , C07C235/64 , C07C235/78 , C07C235/82 , C07C235/84 , C07C237/22 , C07C237/40 , C07C237/42 , C07C239/06 , C07C239/08 , C07C259/06 , C07C271/22 , C07C303/22 , C07C303/40 , C07C309/59 , C07C311/19 , C07D207/34 , C07D207/416 , C07D213/75 , C07D213/81 , C07D295/215 , C07D317/68 , C07D333/38 , A61K31/725 , C07C229/06
CPC分类号： C07D333/38 , A61K38/212 , A61K38/23 , A61K38/27 , A61K38/29 , A61K47/18 , A61K47/183 , A61K47/20 , A61K47/22 , A61K47/4803 , A61K9/0019 , A61K9/1617 , A61K9/4858 , C07C233/34 , C07C233/47 , C07C233/48 , C07C233/51 , C07C233/52 , C07C233/54 , C07C233/55 , C07C233/63 , C07C233/81 , C07C233/83 , C07C233/84 , C07C233/87 , C07C235/24 , C07C235/34 , C07C235/38 , C07C235/40 , C07C235/52 , C07C235/60 , C07C235/64 , C07C235/82 , C07C237/22 , C07C237/40 , C07C237/42 , C07C259/06 , C07C271/22 , C07C309/59 , C07C311/19 , C07D207/34 , C07D213/81 , C07D295/215 , C07D317/68 , A61K9/0043 , A61K9/0056 , C07C2101/14 , C07C2101/18 , C07C2103/74
摘要： Carrier compounds, compositions, and dosage unit forms therefor which are useful in the delivery of active agents are provided. The present invention provides a compound having the formula: ##STR1## or a salt thereof, wherein the compound may be used in a composition or dosage unit form for delivery of at least one active agent, including a peptide, mucopolysaccharide, carbohydrate, or a lipid. Methods of administration and preparation of the compounds and compositions of the invention are provided as well, including oral administration. Further, the compositions of the invention may be prepared by mixing at least one active agent, at least one carrier compound, and, optionally, a dosing vehicle.
摘要翻译：提供了可用于递送活性剂的载体化合物，组合物和剂量单位形式。本发明提供具有下式的化合物或其盐，其中所述化合物可以组合物或剂量单位形式用于递送至少一种活性剂，包括肽，粘多糖，碳水化合物或脂质。还提供了本发明化合物和组合物的施用和制备方法，包括口服给药。此外，本发明的组合物可以通过混合至少一种活性剂，至少一种载体化合物和任选的给药载体来制备。

6. 发明授权

US5072034A Preparation of 4-alkoxy-2-hydroxybenzophenone-5-sulfonic acids 失效
标题翻译： 4-烷基-2-羟基苯并噻吩-5-磺酸的制备
公开(公告)号：US5072034A
公开(公告)日：1991-12-10
申请号：US627895
申请日：1990-12-13
申请人： Peter Neumann , Heinz Eilingsfeld , Alexander Aumueller
发明人： Peter Neumann , Heinz Eilingsfeld , Alexander Aumueller
IPC分类号： C07C309/42 , C07C303/08 , C07C309/44 , C07C309/59
CPC分类号： C07C303/08
摘要： 4-alkoxy-2-hydroxybenzophenone-5-sulfonic acids of the general formula I ##STR1## where R.sup.1 is C.sub.1 -C.sub.20 -alkyl which is unsubstituted or substituted by halogen, cyanao, hydroxyl, C.sub.1 -C.sub.20 -alkoxy, C.sub.2 -C.sub.20 -alkoxycarbonyl, acyloxy and/or phenyl which is unsubstituted or substituted by C.sub.1 -c.sub.4 -alkyl, C.sub.1 -C.sub.4 -alkoxy and/or halogen, R.sup.2 and R.sup.3 independently of one another are each hydrogen, halogen, C.sub.1 -C.sub.12 -alkyl, C.sub.1 -C.sub.12 -alkoxy, C.sub.1 -C.sub.4 -haloalkyl, C.sub.3 -C.sub.8 -cycloalkyl, C.sub.4 -C.sub.12 -cycloalkylalkyl, cyano, hydroxyl or hydroxyethyl or are each phenoxy, C.sub.7 -C.sub.10 -phenalkyl or phenyl which is unsubstituted or substituted by C.sub.1 -C.sub.4 -alkyl, C.sub.1 -C.sub.4 -alkoxy and/or halogen, and R.sup.4 is hydrogen or sulfo, are prepared by reacting a 4-alkoxy-2-hydroxybenzophenone of the general formula II ##STR2## with chlorosulfonic acid at from -20.degree. to +100.degree. C., by a novel and improved process in which the reaction is carried out in an aliphatic, cycloaliphatic and/or aromatic carboxylate as solvent.
摘要翻译：其中R 1是未被取代或被卤素，氰基，羟基，C 1 -C 20烷氧基，C 2 -C 20烷氧基取代的C 1 -C 20烷基的4-烷氧基-2-羟基二苯甲酮-5-磺酸 -C 20 - 烷氧基羰基，未被取代或被C 1 -C 4 - 烷基，C 1 -C 4 - 烷氧基和/或卤素取代的酰氧基和/或苯基，R 2和R 3彼此独立地为氢，卤素，C 1 -C 12 - 烷基 C 1 -C 12烷氧基，C 1 -C 4卤代烷基，C 3 -C 8环烷基，C 4 -C 12环烷基烷基，氰基，羟基或羟乙基，或各自为苯氧基，未取代或被C1- C4-烷基，C1-C4-烷氧基和/或卤素，R4是氢或磺基，是通过使通式II的4-烷氧基-2-羟基二苯甲酮与（II）的4-磺酰基-2- 通过一种新的改进的方法，其中反应在脂族，脂环族和/或芳族羧酸酯作为溶剂中进行。

7. 发明授权

US4153717A Analgesic N-(2-(furylmethylamino and 2 -thienylmethylamino)cyclo aliphatic)benzamides 失效
标题翻译：镇痛N-（2-（呋喃基甲基氨基和2-噻吩基甲基氨基）环脂族）苯甲酰胺
公开(公告)号：US4153717A
公开(公告)日：1979-05-08
申请号：US906271
申请日：1978-05-15
申请人： Jacob Szmuszkovicz
发明人： Jacob Szmuszkovicz
IPC分类号： A61K31/16 , A61K31/165 , A61K31/255 , A61K31/275 , A61K31/34 , A61K31/341 , A61K31/38 , A61K31/381 , A61K31/40 , A61K31/495 , A61P25/00 , C07C67/00 , C07C231/00 , C07C231/02 , C07C233/79 , C07C235/54 , C07C235/84 , C07C253/00 , C07C255/57 , C07C301/00 , C07C303/22 , C07C309/59 , C07C313/00 , C07C315/04 , C07C317/44 , C07C317/46 , C07D207/12 , C07D295/135 , C07D307/52 , C07D333/20 , C07D307/54 , C07D333/24
CPC分类号： C07D295/135
摘要： Cis- and trans-N-(2-aminocycloaliphatic)benzamide compounds of the formula ##STR1## e.g., N-methyl-N-[2-[(2-furylmethyl)methylamino]cyclohexyl]-3,4-dichlorobenzamide, and their pharmaceutically acceptable salts, have been found to have potent analgesic activity, and compositions containing these compounds useful in pharmaceutical dosage unit form for alleviating pain in warm-blooded animals, as well as methods for alleviating pain in animals with these compositions. Processes for preparing the compounds are also disclosed.
摘要翻译：例如N-甲基-N- [2 - [（2-呋喃基甲基）甲基氨基]环己基] -3,4-二氯苯甲酰胺的顺式 - 和反式-N-（2-氨基环脂族）苯甲酰胺化合物，已发现其药学上可接受的盐具有有效的止痛活性，并且含有这些化合物的组合物可用于药物剂量单位形式以减轻温血动物的疼痛，以及用这些组合物减轻动物疼痛的方法。还公开了制备化合物的方法。

8. 发明授权

US09758474B2 Immunomodulator and anti-inflammatory compounds 有权
公开(公告)号：US09758474B2
公开(公告)日：2017-09-12
申请号：US14172707
申请日：2014-02-04
申请人： Rhizen Pharmaceuticals SA , Incozen Therapeutics Pvt. Ltd.
发明人： Meyyappan Muthuppalaniappan , Prashant K. Bhavar , Srikant Viswanadha , Swaroop K. Vakkalanka , Gayatri S. Merikapudi
IPC分类号： A01N37/18 , A01N43/40 , A01N43/32 , A01N43/38 , A61K31/50 , C07D211/72 , C07C233/00 , C12N5/00 , C07C235/56 , C07C233/65 , C07C233/66 , C07C233/75 , C07C309/59 , C07C317/32 , C07C323/42 , C07D209/14 , C07D213/75 , C07D213/81 , C07D231/56 , C07D241/24 , C07D307/79 , C07D317/58 , C07D319/18 , A61K31/167 , A61K31/185 , A61K31/196 , A61K31/343 , A61K31/357 , A61K31/405 , A61K31/416 , A61K31/44 , A61K45/06 , C07C235/84 , C07C309/52
CPC分类号： C07C235/56 , A61K31/167 , A61K31/185 , A61K31/196 , A61K31/343 , A61K31/357 , A61K31/405 , A61K31/416 , A61K31/44 , A61K45/06 , C07C233/65 , C07C233/66 , C07C233/75 , C07C235/84 , C07C309/52 , C07C309/59 , C07C317/32 , C07C323/42 , C07C2601/02 , C07C2601/08 , C07D209/14 , C07D213/75 , C07D213/81 , C07D231/56 , C07D241/24 , C07D307/79 , C07D317/58 , C07D319/18
摘要： The present invention provides dihydroorotate dehydrogenase inhibitors, methods of preparing them, pharmaceutical compositions containing them and methods of treatment, prevention and/or amelioration of diseases or disorders wherein the inhibition of Dihydroorotate dehydrogenase is known to show beneficial effect.

9. 发明申请

US20050101671A1 Compounds and compositions for delivering active agents 失效
标题翻译：用于递送活性剂的化合物和组合物
公开(公告)号：US20050101671A1
公开(公告)日：2005-05-12
申请号：US10617266
申请日：2003-07-09
申请人： Andrea Leone-Bay , Koc-Kan Ho , Donald Sarubbi , Sam Milstein
发明人： Andrea Leone-Bay , Koc-Kan Ho , Donald Sarubbi , Sam Milstein
IPC分类号： C07D295/20 , A61K9/00 , A61K9/08 , A61K9/16 , A61K9/20 , A61K9/48 , A61K31/197 , A61K31/198 , A61K31/40 , A61K31/44 , A61K38/00 , A61K38/04 , A61K38/11 , A61K38/21 , A61K38/22 , A61K38/23 , A61K38/27 , A61K38/28 , A61K38/29 , A61K39/00 , A61K39/395 , A61K45/00 , A61K47/12 , A61K47/16 , A61K47/18 , A61K47/20 , A61K47/22 , A61K47/48 , C07C53/126 , C07C53/134 , C07C229/08 , C07C229/10 , C07C229/42 , C07C231/12 , C07C233/34 , C07C233/47 , C07C233/48 , C07C233/51 , C07C233/52 , C07C233/54 , C07C233/55 , C07C233/63 , C07C233/81 , C07C233/83 , C07C233/84 , C07C233/87 , C07C235/24 , C07C235/34 , C07C235/38 , C07C235/40 , C07C235/52 , C07C235/56 , C07C235/60 , C07C235/62 , C07C235/64 , C07C235/78 , C07C235/82 , C07C235/84 , C07C237/22 , C07C237/40 , C07C237/42 , C07C239/06 , C07C239/08 , C07C259/06 , C07C271/22 , C07C303/22 , C07C303/40 , C07C309/59 , C07C311/19 , C07D207/34 , C07D207/416 , C07D213/75 , C07D213/81 , C07D295/215 , C07D317/68 , C07D333/38 , A61K31/195 , C07C233/67
CPC分类号： C07D333/38 , A61K9/0019 , A61K9/0043 , A61K9/0056 , A61K9/1617 , A61K9/4858 , A61K38/212 , A61K38/23 , A61K38/27 , A61K38/29 , A61K47/18 , A61K47/183 , A61K47/20 , A61K47/22 , A61K47/541 , C07C233/34 , C07C233/47 , C07C233/48 , C07C233/51 , C07C233/52 , C07C233/54 , C07C233/55 , C07C233/63 , C07C233/81 , C07C233/83 , C07C233/84 , C07C233/87 , C07C235/24 , C07C235/34 , C07C235/38 , C07C235/40 , C07C235/52 , C07C235/60 , C07C235/64 , C07C235/82 , C07C237/22 , C07C237/40 , C07C237/42 , C07C259/06 , C07C271/22 , C07C309/59 , C07C311/19 , C07C2601/14 , C07C2601/18 , C07C2603/74 , C07D207/34 , C07D213/81 , C07D295/215 , C07D317/68
摘要： Modified amino acid compounds useful in the delivery of active agents are provided. The active agents can be peptides. Methods of administration, such as oral, subcutaneous, sublingual, and intranasal administration and methods of preparation of the modified amino acid compounds are also provided.
摘要翻译：提供了可用于递送活性剂的改性氨基酸化合物。活性剂可以是肽。还提供了口服，皮下，舌下和鼻内给药的给药方法和修饰的氨基酸化合物的制备方法。

10. 发明授权

US5989539A Compounds and compositions for delivering active agents 失效
公开(公告)号：US5989539A
公开(公告)日：1999-11-23
申请号：US798032
申请日：1997-02-06
申请人： Andrea Leone-Bay , Koc-Kan Ho , Donald J. Sarubbi , Sam J. Milstein
发明人： Andrea Leone-Bay , Koc-Kan Ho , Donald J. Sarubbi , Sam J. Milstein
IPC分类号： C07D295/20 , A61K9/00 , A61K9/08 , A61K9/16 , A61K9/20 , A61K9/48 , A61K31/197 , A61K31/198 , A61K31/40 , A61K31/44 , A61K38/00 , A61K38/04 , A61K38/11 , A61K38/21 , A61K38/22 , A61K38/23 , A61K38/27 , A61K38/28 , A61K38/29 , A61K39/00 , A61K39/395 , A61K45/00 , A61K47/12 , A61K47/16 , A61K47/18 , A61K47/20 , A61K47/22 , A61K47/48 , C07C53/126 , C07C53/134 , C07C229/08 , C07C229/10 , C07C229/42 , C07C231/12 , C07C233/34 , C07C233/47 , C07C233/48 , C07C233/51 , C07C233/52 , C07C233/54 , C07C233/55 , C07C233/63 , C07C233/81 , C07C233/83 , C07C233/84 , C07C233/87 , C07C235/24 , C07C235/34 , C07C235/38 , C07C235/40 , C07C235/52 , C07C235/56 , C07C235/60 , C07C235/62 , C07C235/64 , C07C235/78 , C07C235/82 , C07C235/84 , C07C237/22 , C07C237/40 , C07C237/42 , C07C239/06 , C07C239/08 , C07C259/06 , C07C271/22 , C07C303/22 , C07C303/40 , C07C309/59 , C07C311/19 , C07D207/34 , C07D207/416 , C07D213/75 , C07D213/81 , C07D295/215 , C07D317/68 , C07D333/38 , A61K38/17 , A61K31/725 , C07C229/40
CPC分类号： C07D333/38 , A61K38/212 , A61K38/23 , A61K38/27 , A61K38/29 , A61K47/18 , A61K47/183 , A61K47/20 , A61K47/22 , A61K47/4803 , A61K9/0019 , A61K9/1617 , A61K9/4858 , C07C233/34 , C07C233/47 , C07C233/48 , C07C233/51 , C07C233/52 , C07C233/54 , C07C233/55 , C07C233/63 , C07C233/81 , C07C233/83 , C07C233/84 , C07C233/87 , C07C235/24 , C07C235/34 , C07C235/38 , C07C235/40 , C07C235/52 , C07C235/60 , C07C235/64 , C07C235/82 , C07C237/22 , C07C237/40 , C07C237/42 , C07C259/06 , C07C271/22 , C07C309/59 , C07C311/19 , C07D207/34 , C07D213/81 , C07D295/215 , C07D317/68 , A61K9/0043 , A61K9/0056 , C07C2101/14 , C07C2101/18 , C07C2103/74
摘要： Carrier compounds, compositions, and dosage unit forms therefor which are useful in the delivery of active agents are provided. The present invention provides a compound having the formula: ##STR1## or a salt thereof, wherein the compound may be used in a composition or dosage unit form for delivery of at least one active agent, including a peptide, mucopolysaccharide, carbohydrate, or a lipid. Methods of administration and preparation of the compounds and compositions of the invention are provided as well, including oral administration. Further, the compositions of the invention may be prepared by mixing at least one active agent, at least one carrier compound, and, optionally, a dosing vehicle.

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式